Low bacterial diet versus control diet to prevent infection in cancer patients treated with chemotherapy causing episodes of neutropenia.
Affiliation
Department of Paediatric Oncology, Emma Children’s Hospital / Academic Medical Center, Amsterdam, Netherlands.Issue Date
2012
Metadata
Show full item recordAbstract
Neutropenia is a potentially serious side effect of chemotherapy and a major risk factor for infections, which can be life-threatening. It has been hypothesised that a low bacterial diet (LBD) can prevent the occurrence of infections and (infection-related) mortality in cancer patients receiving chemotherapy causing episodes of neutropenia, but much remains unclear.Citation
Low bacterial diet versus control diet to prevent infection in cancer patients treated with chemotherapy causing episodes of neutropenia. 2012, 9:CD006247 Cochrane Database Syst RevJournal
Cochrane Database of Systematic ReviewsDOI
10.1002/14651858.CD006247.pub2PubMed ID
22972091Type
ArticleLanguage
enISSN
1469-493Xae974a485f413a2113503eed53cd6c53
10.1002/14651858.CD006247.pub2
Scopus Count
Collections
Related articles
- Low bacterial diet versus control diet to prevent infection in cancer patients treated with chemotherapy causing episodes of neutropenia.
- Authors: van Dalen EC, Mank A, Leclercq E, Mulder RL, Davies M, Kersten MJ, van de Wetering MD
- Issue date: 2016 Apr 24
- Medical interventions for the prevention of platinum-induced hearing loss in children with cancer.
- Authors: van As JW, van den Berg H, van Dalen EC
- Issue date: 2012 May 16
- Medical interventions for the prevention of platinum-induced hearing loss in children with cancer.
- Authors: van As JW, van den Berg H, van Dalen EC
- Issue date: 2014 Jul 1
- Systemic treatments for the prevention of venous thrombo-embolic events in paediatric cancer patients with tunnelled central venous catheters.
- Authors: Schoot RA, Kremer LC, van de Wetering MD, van Ommen CH
- Issue date: 2013 Sep 11
- Prophylactic antibiotics or G(M)-CSF for the prevention of infections and improvement of survival in cancer patients receiving myelotoxic chemotherapy.
- Authors: Skoetz N, Bohlius J, Engert A, Monsef I, Blank O, Vehreschild JJ
- Issue date: 2015 Dec 21